These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26207782)

  • 1. Heparin Anticoagulation Monitoring in Patients Supported by Ventricular Assist Devices.
    Schweiger M; Hübler M; Albisetti M
    ASAIO J; 2015; 61(5):487-8. PubMed ID: 26207782
    [No Abstract]   [Full Text] [Related]  

  • 2. Developing an Anti-Xa-Based Anticoagulation Protocol for Patients with Percutaneous Ventricular Assist Devices.
    Sieg A; Mardis BA; Mardis CR; Huber MR; New JP; Meadows HB; Cook JL; Toole JM; Uber WE
    ASAIO J; 2015; 61(5):502-8. PubMed ID: 26273933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hemolysis with intravenous unfractionated heparin using an antifactor Xa-based monitoring protocol.
    Adatya S; John R; Eckman PM
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1465-6. PubMed ID: 25983257
    [No Abstract]   [Full Text] [Related]  

  • 4. Gold standard in anticoagulation assessment of left ventricular assist device patients?: how about bronze.
    Stehlik J; Johnson SA; Selzman CH
    JACC Heart Fail; 2015 Apr; 3(4):323-6. PubMed ID: 25770402
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulation monitoring during extracorporeal membrane oxygenation: is anti-factor Xa assay (heparin level) a better test?*.
    Nguyen T; Musick M; Teruya J
    Pediatr Crit Care Med; 2014 Feb; 15(2):178-9. PubMed ID: 24492189
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support.
    Adatya S; Uriel N; Yarmohammadi H; Holley CT; Feng A; Roy SS; Reding MT; John R; Eckman P; Zantek ND
    JACC Heart Fail; 2015 Apr; 3(4):314-22. PubMed ID: 25770404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device.
    Ghez O; Liesner R; Karimova A; Ng C; Goldman A; van Doorn C
    ASAIO J; 2006; 52(6):705-7. PubMed ID: 17117062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices.
    Adatya S; Sunny R; Fitzpatrick MJ; Colvin M; Thennapan T; John R; Dodge Zantek N; Pritzker M; Eckman P; Uriel N
    J Heart Lung Transplant; 2016 Nov; 35(11):1311-1320. PubMed ID: 27836023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfractionated Heparin Protocol During Percutaneous Left Ventricular Mechanical Circulatory (Impella) Support.
    Lee MC; Peters C; Rai N; Safani M; Thomas GS
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):251-253. PubMed ID: 30572718
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
    Chia S; Van Cott EM; Raffel OC; Jang IK
    Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood hypercoagulability despite anticoagulation during mechanical cardiac assist.
    Niemi TT; Kukkonen SI; Hämmäinen PT; Suojaranta-Ylinen RT; Sipponen JT
    Perfusion; 2008 Mar; 23(2):107-10. PubMed ID: 18840579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
    Vandiver JW; Vondracek TG
    Hosp Pract (1995); 2013 Apr; 41(2):16-24. PubMed ID: 23545756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring heparin anticoagulation in the acute phase response.
    Uprichard J; Manning RA; Laffan MA
    Br J Haematol; 2010 May; 149(4):613-9. PubMed ID: 20230412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation for pediatric mechanical circulatory support.
    Annich G; Adachi I
    Pediatr Crit Care Med; 2013 Jun; 14(5 Suppl 1):S37-42. PubMed ID: 23735984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.
    Vandiver JW; Vondracek TG
    Pharmacotherapy; 2012 Jun; 32(6):546-58. PubMed ID: 22531940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.
    Liveris A; Bello RA; Friedmann P; Duffy MA; Manwani D; Killinger JS; Rodriquez D; Weinstein S
    Pediatr Crit Care Med; 2014 Feb; 15(2):e72-9. PubMed ID: 24335992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues with monitoring of unfractionated heparin in cirrhosis.
    Potze W; Lisman T
    Ther Drug Monit; 2015 Apr; 37(2):279-80. PubMed ID: 25265256
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of anti-Xa and activated partial thromboplastin time monitoring for heparin dosing in patients with cirrhosis.
    Fuentes A; Gordon-Burroughs S; Hall JB; Putney DR; Monsour HP
    Ther Drug Monit; 2015 Feb; 37(1):40-4. PubMed ID: 24901494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.